⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JAGX News
Jaguar Health, Inc.
Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
accessnewswire.com
JAGX
Form 8-K/A
sec.gov
JAGX
Form 8-K
sec.gov
JAGX
Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
accessnewswire.com
JAGX
Form 8-K
sec.gov
JAGX
Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filament Health Ready to Announce with Confidence?
newsfilecorp.com
JAGX
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention
accessnewswire.com
JAGX
Jaguar Health Presenting June 24, 2026 at the Life Sciences Virtual Investor Forum to Provide Updates on Company's Crofelemer Development Program for Rare Intestinal Failure Diseases
accessnewswire.com
JAGX
Form 8-K
sec.gov
JAGX
Presenting on Emerging Growth Conference 93 Day 2 on June 11; Register to live stream
globenewswire.com
CIA
ZENA
JAGX
USAU
JUNS
VGZ
VWAV
EEIQ
SBC
NWTG
NVA
UMAC
MTVA